Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Apr 14:22:101087.
doi: 10.1016/j.ajoc.2021.101087. eCollection 2021 Jun.

Case report: The use of netarsudil to improve corneal edema after laser peripheral iridotomy and Descemet's membrane endothelial keratoplasty

Affiliations
Case Reports

Case report: The use of netarsudil to improve corneal edema after laser peripheral iridotomy and Descemet's membrane endothelial keratoplasty

Sabrina L Chen et al. Am J Ophthalmol Case Rep. .

Abstract

Purpose: To report a case in which netarsudil ophthalmic solution 0.02% improved refractory corneal edema after laser peripheral iridotomy (LPI) and Descemet's membrane endothelial keratoplasty (DMEK).

Observations: A 63-year-old female presented with decreased vision due to corneal edema secondary to iatrogenic endothelial cell loss from previous YAG and argon laser peripheral iridotomy. Initial treatment with topical sodium chloride 5% solution was unsuccessful in resolving the edema. As a result, topical netarsudil was initiated off-label. Improvement in corneal thickness and visual acuity was noted, but after a few months, the left eye decompensated with worsening edema. Cataract surgery with DMEK was performed. Surgery was prolonged and intraoperative floppy iris was encountered. Post-operatively, the patient's best-corrected visual acuity (VA) fluctuated between 20/30 to 20/70 with persistent corneal edema. The central corneal thickness (CCT) ranged from 758 to 779 three months after surgery. Topical netarsudil was started again off-label for cornea edema once nightly. Over the next two months, visual acuity and CCT improved to 20/25 and 650, respectively. Stabilization of visual acuity and cornea edema has been maintained for eight months after initiation of topical netarsudil.

Conclusions: Netarsudil, a commercially available rho-kinase inhibitor, may be an effective, non-invasive adjunctive therapy for refractory corneal edema. Our case demonstrates improvement in BCVA and CCT using topical netarsudil, which has been maintained without any vision threatening side effects.

Keywords: Corneal edema; DMEK; LPI; Netarsudil; Rho-kinase inhibitors.

PubMed Disclaimer

Conflict of interest statement

No conflicts of interest to report.

Figures

Fig. 1
Fig. 1
A) Superior microcystic and stromal edema extending to the visual axis in the left eye. B) Microcystic edema progressed to stromal edema with Descemet's folds in the left eye as endothelial cell loss continued.
Fig. 2
Fig. 2
Specular microscopy showed regular endothelial cells OD with a count of 2151. No cells could be visualized OS due to the corneal edema.
Fig. 3
Fig. 3
A) Persistent stromal edema several weeks after successful re-bubbling of the inferior DMEK graft. B) Interval improvement of cornea edema two months after topical netarsudil.

Similar articles

Cited by

References

    1. Okumura N., Koizumi N., Kay E.P. The ROCK inhibitor eye drop accelerates corneal endothelium wound healing. Invest Ophthalmol Vis Sci. 2013;54(4):2493–2502. doi: 10.1167/iovs.12-11320. - DOI - PubMed
    1. Okumura N., Okazaki Y., Inoue R. Effect of the rho-associated kinase inhibitor eye drop (Ripasudil) on corneal endothelial wound healing. Invest Ophthalmol Vis Sci. 2016;57(3):1284–1292. doi: 10.1167/iovs.15-18586. - DOI - PubMed
    1. Koizumi N., Okumura N., Ueno M., Kinoshita S. New therapeutic modality for corneal endothelial disease using rho-associated kinase inhibitor eye drops. Cornea. 2014;33:S25–S31. doi: 10.1097/ICO.0000000000000240. - DOI - PubMed
    1. Moloney G., Petsoglou C., Ball M. Descemetorhexis without grafting for Fuchs endothelial dystrophy—supplementation with topical Ripasudil. Cornea. 2017;36(6):642–648. doi: 10.1097/ICO.0000000000001209. - DOI - PubMed
    1. Ploysangam P., Patel S.P. A case report illustrating the postoperative course of descemetorhexis without endothelial keratoplasty with topical netarsudil therapy. Case Rep. Ophthalmol. Med. 2019 doi: 10.1155/2019/6139026. - DOI - PMC - PubMed

Publication types

LinkOut - more resources